EP3030142A4 - Intraabdominaler druck zur förderung von hämostase und überleben - Google Patents

Intraabdominaler druck zur förderung von hämostase und überleben Download PDF

Info

Publication number
EP3030142A4
EP3030142A4 EP14835065.5A EP14835065A EP3030142A4 EP 3030142 A4 EP3030142 A4 EP 3030142A4 EP 14835065 A EP14835065 A EP 14835065A EP 3030142 A4 EP3030142 A4 EP 3030142A4
Authority
EP
European Patent Office
Prior art keywords
intra
survival
abdominal pressure
promote hemostasis
hemostasis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP14835065.5A
Other languages
English (en)
French (fr)
Other versions
EP3030142A1 (de
Inventor
Adam Rago
John Marini
Gregory T. Zugates
Marc Helmick
Upma Sharma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arsenal Medical Inc
Original Assignee
Arsenal Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arsenal Medical Inc filed Critical Arsenal Medical Inc
Publication of EP3030142A1 publication Critical patent/EP3030142A1/de
Publication of EP3030142A4 publication Critical patent/EP3030142A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
    • A61B17/12186—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices liquid materials adapted to be injected
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
    • A61B17/1219—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices expandable in contact with liquids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00637—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for sealing trocar wounds through abdominal wall
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00641—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closing fistulae, e.g. anorectal fistulae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00646—Type of implements
    • A61B2017/00654—Type of implements entirely comprised between the two sides of the opening
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831—Material properties
    • A61B2017/00898—Material properties expandable upon contact with fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B2017/12004—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord for haemostasis, for prevention of bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Surgical Instruments (AREA)
EP14835065.5A 2013-08-09 2014-08-08 Intraabdominaler druck zur förderung von hämostase und überleben Withdrawn EP3030142A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361864368P 2013-08-09 2013-08-09
PCT/US2014/050332 WO2015021375A1 (en) 2013-08-09 2014-08-08 Intra-abdominal pressure to promote hemostasis and survival

Publications (2)

Publication Number Publication Date
EP3030142A1 EP3030142A1 (de) 2016-06-15
EP3030142A4 true EP3030142A4 (de) 2017-08-09

Family

ID=52461959

Family Applications (1)

Application Number Title Priority Date Filing Date
EP14835065.5A Withdrawn EP3030142A4 (de) 2013-08-09 2014-08-08 Intraabdominaler druck zur förderung von hämostase und überleben

Country Status (6)

Country Link
EP (1) EP3030142A4 (de)
JP (1) JP2016531668A (de)
AU (1) AU2014305771A1 (de)
CA (1) CA2919856A1 (de)
IL (1) IL244011A0 (de)
WO (1) WO2015021375A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10293076B2 (en) 2011-08-12 2019-05-21 Arsenal Medical, Inc. Intra-abdominal pressure to promote hemostasis and survival
US9358042B2 (en) 2013-03-13 2016-06-07 The Spectranetics Corporation Expandable member for perforation occlusion
US10499892B2 (en) 2015-08-11 2019-12-10 The Spectranetics Corporation Temporary occlusion balloon devices and methods for preventing blood flow through a vascular perforation
US10449336B2 (en) 2015-08-11 2019-10-22 The Spectranetics Corporation Temporary occlusions balloon devices and methods for preventing blood flow through a vascular perforation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6520977B2 (en) * 1999-12-06 2003-02-18 Hadi Piraka Uterine balloon apparatus and method
US20040013715A1 (en) * 2001-09-12 2004-01-22 Gary Wnek Treatment for high pressure bleeding
US8828358B2 (en) * 2008-03-11 2014-09-09 Materials Modifications, Inc. In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide
US10420862B2 (en) * 2009-08-24 2019-09-24 Aresenal AAA, LLC. In-situ forming foams for treatment of aneurysms
US20110202016A1 (en) * 2009-08-24 2011-08-18 Arsenal Medical, Inc. Systems and methods relating to polymer foams
EP2741788A4 (de) * 2011-08-14 2015-03-25 Materials Modification Inc Verfahren und zusammensetzung zur in-situ-bildung einer künstlichen sperre zur bekämpfung von blutverlust
US8993831B2 (en) * 2011-11-01 2015-03-31 Arsenal Medical, Inc. Foam and delivery system for treatment of postpartum hemorrhage

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MICHAEL DUGGAN ET AL: "Self-expanding polyurethane polymer improves survival in a model of noncompressible massive abdominal hemorrhage", JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, vol. 74, no. 6, 1 June 2013 (2013-06-01), US, pages 1462 - 1467, XP055351157, ISSN: 2163-0755, DOI: 10.1097/TA.0b013e31828da937 *

Also Published As

Publication number Publication date
JP2016531668A (ja) 2016-10-13
IL244011A0 (en) 2016-04-21
CA2919856A1 (en) 2015-02-12
EP3030142A1 (de) 2016-06-15
WO2015021375A1 (en) 2015-02-12
AU2014305771A1 (en) 2016-02-18

Similar Documents

Publication Publication Date Title
EP3043784A4 (de) Arylether und verwendungen davon
EP3030566A4 (de) Aza-pyridon-verbindungen und verwendungen davon
CA2874913A1 (en) Multi-stage well isolation and fracturing
EP2970909A4 (de) Verfahren und zusammensetzungen in zusammenhang mit t-zell aktivität
EP3004833A4 (de) Verbesserungen an und in zusammenhang mit gewebeproben
EP3062867A4 (de) Endoskopische und perkutane chirurgie mit kontrolliertem druck
EP2983681A4 (de) Therapeutische zusammensetzungen und verwendungen davon
EP3060724A4 (de) Verbesserungen an und in zusammenhang mit kopplern
EP3065170A4 (de) Druckstruktur und presseinheit
EP3071236A4 (de) Injizierbares gewebesupplement
EP3068443A4 (de) Residualisierungsvernetzer und verwendungen davon
EP3054974A4 (de) Glycaninteragierende verbindungen und verfahren zur verwendung
EP3048108A4 (de) Thienopiperidinderivat und verwendung davon
EP3007557A4 (de) Herstellung von (s, s) -secoisolariciresinoldiglucosid und (r, r)-secoisolariciresinoldiglucosid
EP3037097A4 (de) Polyrotaxan und medizinische zusammensetzung damit
EP3008243A4 (de) Geschichtete gewebestrukturen mit makroalgen
EP3019451A4 (de) Hochporöse aerogele
EP3049711A4 (de) Druckisolationsverteiler
EP3060061A4 (de) Verwendung von probiotika in fleisch
EP3063000A4 (de) Dauerhaftes krepppapier
EP3060924A4 (de) Pif-transfizierte zellen und verfahren zur verwendung
IL244011A0 (en) Intra-abdominal pressure to promote hemostasis and survival
EP3037052A4 (de) Trokar
EP3063383A4 (de) Turbolader mit vorverstärkungskonfiguration
EP3027182A4 (de) Neuartiges kupfercysteamin und verfahren zur verwendung

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20160219

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20170711

RIC1 Information provided on ipc code assigned before grant

Ipc: A61B 5/00 20060101AFI20170706BHEP

Ipc: A61B 5/02 20060101ALI20170706BHEP

Ipc: A61B 5/022 20060101ALI20170706BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20180208